【九强生物：持股5%以上股东计划减持不超过0.11%股份】金融界2月17日消息，九强生物公告称，持有公司股份3096.96万股（占公司有表决权股份比例为5.30%）的自然人股东ZHOU XIAOYAN女士计划自本公告披露之日起十五个交易日后的三个月内以集中竞价和/或大宗交易方式减持本公司股份，计划减持数量不超过61.94万股（占公司有表决权股份比例的0.11%）。

金融界2025-02-17

金融界2月17日消息，九强生物公告称，持有公司股份3096.96万股（占公司有表决权股份比例为5.30%）的自然人股东ZHOU XIAOYAN女士计划自本公告披露之日起十五个交易日后的三个月内以集中竞价和/或大宗交易方式减持本公司股份，计划减持数量不超过61.94万股（占公司有表决权股份比例的0.11%）。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2512941138?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-17 19:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2512941138","market":"sh","top_or_hot":-1,"title":"【九强生物：持股5%以上股东计划减持不超过0.11%股份】金融界2月17日消息，九强生物公告称，持有公司股份3096.96万股（占公司有表决权股份比例为5.30%）的自然人股东ZHOU XIAOYAN女士计划自本公告披露之日起十五个交易日后的三个月内以集中竞价和/或大宗交易方式减持本公司股份，计划减持数量不超过61.94万股（占公司有表决权股份比例的0.11%）。","media":"金融界","content":"<div>\n<p>金融界2月17日消息，九强生物公告称，持有公司股份3096.96万股（占公司有表决权股份比例为5.30%）的自然人股东ZHOU XIAOYAN女士计划自本公告披露之日起十五个交易日后的三个月内以集中竞价和/或大宗交易方式减持本公司股份，计划减持数量不超过61.94万股（占公司有表决权股份比例的0.11%）。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/02/17195848207527.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【九强生物：持股5%以上股东计划减持不超过0.11%股份】金融界2月17日消息，九强生物公告称，持有公司股份3096.96万股（占公司有表决权股份比例为5.30%）的自然人股东ZHOU XIAOYAN女士计划自本公告披露之日起十五个交易日后的三个月内以集中竞价和/或大宗交易方式减持本公司股份，计划减持数量不超过61.94万股（占公司有表决权股份比例的0.11%）。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【九强生物：持股5%以上股东计划减持不超过0.11%股份】金融界2月17日消息，九强生物公告称，持有公司股份3096.96万股（占公司有表决权股份比例为5.30%）的自然人股东ZHOU XIAOYAN女士计划自本公告披露之日起十五个交易日后的三个月内以集中竞价和/或大宗交易方式减持本公司股份，计划减持数量不超过61.94万股（占公司有表决权股份比例的0.11%）。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-17 19:58 北京时间&nbsp;&nbsp;&nbsp;<a href=https://24h.jrj.com.cn/2025/02/17195848207527.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>金融界2月17日消息，九强生物公告称，持有公司股份3096.96万股（占公司有表决权股份比例为5.30%）的自然人股东ZHOU XIAOYAN女士计划自本公告披露之日起十五个交易日后的三个月内以集中竞价和/或大宗交易方式减持本公司股份，计划减持数量不超过61.94万股（占公司有表决权股份比例的0.11%）。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/02/17195848207527.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0077","symbol_name":"质押式回购","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/02/17195848207527.shtml","article_id":"2512941138","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2512941138","pubTimestamp":1739793492,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"金融界2月17日消息，九强生物公告称，持有公司股份3096.96万股（占公司有表决权股份比例为5.30%）的自然人股东ZHOU XIAOYAN女士计划自本公告披露之日起十五个交易日后的三个月内以集中竞价和/或大宗交易方式减持本公司股份，计划减持数量不超过61.94万股（占公司有表决权股份比例的0.11%）。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300406":"九强生物","BK0077":"质押式回购","BK0046":"生物疫苗","BK0028":"国家队","BK0239":"医药制造","BK0012":"证金概念"},"translate_title":"[Jiuqiang Biotech: Shareholders holding more than 5% of the shares plan to reduce their holdings by no more than 0.11% of the shares] According to news from the financial circles on February 17, Jiuqiang Biotech announced that it holds 30.9696 million shares of the company (accounting for 5.30% of the company's voting shares) Ms. ZHOU XIAOYAN, a natural person shareholder, plans to reduce her holdings of the company's shares through centralized bidding and/or block transactions within three months after fifteen trading days from the date of disclosure of this announcement. The planned reductio","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300406":1},"content_text":"金融界2月17日消息，九强生物公告称，持有公司股份3096.96万股（占公司有表决权股份比例为5.30%）的自然人股东ZHOU XIAOYAN女士计划自本公告披露之日起十五个交易日后的三个月内以集中竞价和/或大宗交易方式减持本公司股份，计划减持数量不超过61.94万股（占公司有表决权股份比例的0.11%）。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2512941138","isCrawlerRequest":true}